Miraglia Dennis, Miguel Lourdes A
Department of Internal Medicine, Good Samaritan Hospital, Aguadilla, Puerto Rico.
J Innov Card Rhythm Manag. 2020 Jun 15;11(6):4129-4133. doi: 10.19102/icrm.2020.110603. eCollection 2020 Jun.
Double defibrillation (DD) has been proposed as an alternative treatment for patients with refractory ventricular fibrillation/pulseless ventricular tachycardia (VF/pVT) out-of-hospital cardiac arrest (OHCA) nonresponsive to the best current standard of care. Treatment results are promising, but the efficacy and safety of the procedure remain unclear. Currently, there is a paucity of evidence in the literature on DD suggesting the optimal strategy for treating this challenging patient population. Thus, we aim to perform a scoping review to explore the current literature addressing resuscitative parameters, survival rates, and neurological outcomes in refractory VF/pVT OHCA patients treated with DD as well as to identify gaps in the literature that may require further research. Here, we discuss the anticipated study protocol.
双次除颤(DD)已被提议作为院外心脏骤停(OHCA)患者难治性室颤/无脉性室性心动过速(VF/pVT)的一种替代治疗方法,这些患者对当前最佳标准治疗无反应。治疗结果很有前景,但该操作的有效性和安全性仍不明确。目前,文献中关于双次除颤的证据很少,无法为治疗这一具有挑战性的患者群体提供最佳策略。因此,我们旨在进行一项范围综述,以探索当前关于接受双次除颤治疗的难治性VF/pVT OHCA患者的复苏参数、生存率和神经学结局的文献,并确定文献中可能需要进一步研究的空白。在此,我们讨论预期的研究方案。